
Progestin-Primed Ovarian Stimulation is a non-inferior alternative to the GnRH Antagonist Protocol in patients undergoing assisted reproductive techniques: a retrospective study
Author(s) -
João Pedro Junqueira Caetano,
Luciana Campomizzi Calazans,
Leci Veiga Caetano Amorim,
Leonardo Matheus Ribeiro Pereira,
Erica Becker Sousa Xavier,
Arlene Campos,
Bruna Barbosa Coimbra,
Ricardo Mello Marinho
Publication year - 2022
Publication title -
jbra
Language(s) - English
Resource type - Journals
eISSN - 1518-0557
pISSN - 1517-5693
DOI - 10.5935/1518-0557.20210057
Subject(s) - progestin , medicine , antagonist , gonadotropin releasing hormone antagonist , ovulation , pregnancy rate , hormone antagonist , blastocyst , ovulation induction , pregnancy , gynecology , andrology , gonadotropin releasing hormone , endocrinology , hormone , luteinizing hormone , biology , embryo , receptor , embryogenesis , genetics , microbiology and biotechnology
To demonstrate the non-inferiority of Clinical Pregnancy Rates from Progestin-Primed Ovarian Stimulation compared to the GnRH Antagonist Protocol when the freeze-all and blastocyst transfer strategy is applied.